A Comparative evaluation between the efficacy of IVIG and Methylprednisolone in primery treatment of immune thrombocytopenic purpura in children.
Not Applicable
- Conditions
- Idiopathic Thrombocytopenic Purpura.Evans Syndrome
- Registration Number
- IRCT2016121831456N1
- Lead Sponsor
- Deputy of Research and Development of Ahvaz Jundishapour university of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
platelet count less than 20 × 109/L (20,000/ L); Isolated thrombocytopenia; increase number of megacaryocytes in an otherwise normal bone marrow: :Exclusion criteria: Bone marrow transplant; Systemic Lupus Erythematous; Ant phospholipid Syndrome; Evans Syndrome; Leukemia; Myelophthisic Infiltration; Myelodysplasia; Aplastic Anemia
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood Platelet. Timepoint: Two days after treatment . Five days after treatment. Method of measurement: Count of Platelets in blood microliter measured by Sysmex kx21.
- Secondary Outcome Measures
Name Time Method